XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock (NQ:XOMAP)

25.42 +0.02 (+0.08%)

Streaming Delayed Price Updated: 2:01 PM EDT, Jun 17, 2026 Add to My Watchlist

Price and Volume

Volume	1,113
Open	25.43
Bid (Size)	25.42 (7,900)
Ask (Size)	25.44 (400)
Prev. Close	25.40
Today's Range	25.42 - 25.43
52wk Range	25.14 - 30.00
Shares Outstanding	N/A
Dividend Yield	8.48%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

June 12, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA ROYALTY CORP (NASDAQ:XOMAP) Passes Navellier’s Little Book Growth Screen with Strong Momentum ↗

May 14, 2026

Via Chartmill

Performance

YTD	-6.2%	-6.2%
1 Month	+0.2%	+0.2%
3 Month	-1.3%	-1.3%
6 Month	-5.0%	-5.0%
1 Year	-0.9%	-0.9%

More News

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

April 27, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA ROYALTY CORP - XOMA 8 5/8 PERP (NASDAQ:XOMAP) Shines in Growth Screen from Navellier's 'Little Book That Makes You Rich' ↗

April 22, 2026

Via Chartmill

XOMA Royalty Corp (NASDAQ:XOMAP) Screened as a High-Growth Stock Using Navellier's Strategy ↗

March 31, 2026

Via Chartmill

XOMA Royalty Declares Quarterly Preferred Stock Dividends

March 18, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

March 18, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

March 12, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty to Present at Investor Conferences in March

February 18, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

February 09, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Announces CFO Transition

January 12, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

December 30, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Declares Quarterly Preferred Stock Dividends

December 22, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc

December 05, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.

November 21, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

November 12, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

October 17, 2025

From XOMA Royalty Corporation; LAVA Therapeutics N.V.

Via GlobeNewswire

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

October 02, 2025

From XOMA Royalty Corporation; LAVA Therapeutics

Via GlobeNewswire

XOMA Royalty Declares Quarterly Preferred Stock Dividends

September 22, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.

September 17, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference

September 03, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

August 20, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

August 13, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics

August 11, 2025

From XOMA Royalty Corporation

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 07, 2025

Via Benzinga

Frequently Asked Questions

Is XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock publicly traded?

Yes, XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is publicly traded.

What exchange does XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock trade on?

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock trades on the Nasdaq Stock Market

What is the ticker symbol for XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock?

The ticker symbol for XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is XOMAP on the Nasdaq Stock Market

What is the current price of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock?

The current price of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is 25.42

When was XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock last traded?

The last trade of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock was at 06/17/26 02:01 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.